AACR meeting
This article was originally published in The Tan Sheet
Executive Summary
American Association for Cancer Research's annual meeting will take place July 11-14 at the Washington Convention Center in Washington, D.C., according to notice posted on group's 1Web site April 23. Initially scheduled to occur April 5-9 in Toronto, the meeting was postponed due to concerns about SARS. Research slated for presentation at the meeting includes a report on weekly NSAID use and its effect on reducing breast cancer incidence, study finding black cohosh may increase chemotherapy drugs' effectiveness (2"The Tan Sheet" April 21, 2003, p. 16)...
You may also be interested in...
American Association For Cancer Research In Brief
The AACR annual meeting, scheduled to be held in Toronto April 5-9, was cancelled due to concerns about the SARS outbreak. However, research abstracts were still submitted to the association.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.